Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Avaria Health & Beauty Corp.
WARNING LETTER
•Avaria Health & Beauty Corp.•August 8, 2023

Avaria Health & Beauty Corp. – FDA Warning Letter, Aug 8, 2023

Record Details

The FDA issued a Warning Letter to Avaria Health & Beauty Corp. on August 3, 2023, following a review of records submitted on January 25, 2023, under section 704(a)(4) of the FD&C Act. The facility, registered as an OTC drug manufacturer, was found to have significant Current Good Manufacturing Practice (CGMP) violations, rendering its drug products adulterated under 21 U.S.C. 351(a)(2)(B).

Key violations include: 1. **Failure to conduct identity testing for components (21 CFR 211.84(d)(1)):** The firm did not adequately test high-risk components like glycerin for diethylene glycol (DEG) or ethylene glycol (EG) contamination using USP identity tests, failing to ensure component acceptability. 2. **Inadequate quality control unit (21 CFR 211.22(a)):** The Quality Unit (QU) did not effectively oversee drug manufacturing, specifically failing to approve or reject components in the Materials System, raising concerns about oversight in other CGMP operations.

The FDA recommends engaging a qualified CGMP consultant to evaluate operations, perform a comprehensive six-system audit, and assess corrective actions. The firm was placed on Import Alert 66-40 on April 14, 2023. A written response detailing

Company
Avaria Health & Beauty Corp.
Inspection date
August 8, 2023
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · 03c12504-95fe-4efc-9ccd-972727849a03

Violation Codes5
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.84(d)(1)21 CFR 211.22(a)

Full citation text and observation details available on the Dashboard.

Other documents for Avaria Health & Beauty Corp.
  • WARNING_LETTER - 2024-04-30April 30, 2024

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Avaria Health & Beauty Corp.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.